Sign up to save your podcasts
Or
Share Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more
May 09, 2017 edition of the weekly JAMA Editors' Summary
View all episodes
By JAMA Network
3.9
127127 ratings
May 09, 2017 edition of the weekly JAMA Editors' Summary
More shows like JAMA Editors' Summary
View all
NEJM This Week
317 Listeners
AFP: American Family Physician Podcast
695 Listeners
JAMA Clinical Reviews
498 Listeners
This Week in Cardiology
884 Listeners
Mayo Clinic Talks
296 Listeners
Frankly Speaking About Family Medicine
260 Listeners
The Curbsiders Internal Medicine Podcast
3,342 Listeners
Core IM | Internal Medicine Podcast
1,147 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Critical Care Scenarios
261 Listeners
Cardionerds: A Cardiology Podcast
428 Listeners
The Curious Clinicians
370 Listeners
Critical Care Time
272 Listeners